Clement Morgat

CNRS UMR 5287, LabEx TRAIL
Pessac-sur-dordogne, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Sleep's influence on susceptibility to motion sickness in parabolic flights and virtual reality: An exploratory study.

Sleep's influence on susceptibility to motion sickness in parabolic flights and virtual reality: An exploratory study.

Journal: Journal of vestibular research : equilibrium & orientation

Published: August 11, 2026

Fully GMP-complient radiosynthesis of [161Tb]Tb-PSMA-1 using the miniAiO synthesizer for clinical translation.

Fully GMP-complient radiosynthesis of [161Tb]Tb-PSMA-1 using the miniAiO synthesizer for clinical translation.

Journal: EJNMMI radiopharmacy and chemistry

Published: May 27, 2026

Terbium-161 might be superior to lutetium-177 for oligometastases.

Terbium-161 might be superior to lutetium-177 for oligometastases.

Journal: The Lancet. Oncology

Published: May 25, 2026

Prospective head-to-head comparison of [68Ga]Ga-RM2 PET/CT and [68Ga]Ga-PSMA-617 PET/CT in newly diagnosed patients with intermediate-risk localized prostate cancer.

Prospective head-to-head comparison of [68Ga]Ga-RM2 PET/CT and [68Ga]Ga-PSMA-617 PET/CT in newly diagnosed patients with intermediate-risk localized prostate cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: December 22, 2025

Diagnostic accuracy of [18F]-FDG-PET/CT for lymph node staging in bladder cancer prior to radical cystectomy.

Diagnostic accuracy of [18F]-FDG-PET/CT for lymph node staging in bladder cancer prior to radical cystectomy.

Journal: World journal of urology

Published: November 18, 2025

Persistent lymph node uptake on [18 F]-FDG PET-CT after neoadjuvant chemotherapy: a major predictive factor of disease-free survival in MIBC.

Persistent lymph node uptake on [18 F]-FDG PET-CT after neoadjuvant chemotherapy: a major predictive factor of disease-free survival in MIBC.

Journal: World journal of urology

Published: September 26, 2025

GRPR Expression in Metastatic Cancers: A Review of Potential Application of GRPR-Radioligand Therapy.

GRPR Expression in Metastatic Cancers: A Review of Potential Application of GRPR-Radioligand Therapy.

Journal: Seminars in nuclear medicine

Published: June 28, 2025

N-Terminal Stabilization of Radiolabeled Neurotensin Analogues for Improved Tumor Uptake.

N-Terminal Stabilization of Radiolabeled Neurotensin Analogues for Improved Tumor Uptake.

Journal: Journal of medicinal chemistry

Published: March 20, 2025

A Vision for Gastrin-Releasing Peptide Receptor Targeting for Imaging and Therapy: Perspective from Academia and Industry.

A Vision for Gastrin-Releasing Peptide Receptor Targeting for Imaging and Therapy: Perspective from Academia and Industry.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: December 29, 2024

Prostate-specific membrane antigen (PSMA) expression in primary and metastatic renal cell cancer (UroCCR-65 study).

Prostate-specific membrane antigen (PSMA) expression in primary and metastatic renal cell cancer (UroCCR-65 study).

Journal: EJNMMI research

Published: November 08, 2024

Design and Synthesis of 68Ga-Labeled Peptide-Based Heterodimers for Dual Targeting of NTS1 and GRPR.

Design and Synthesis of 68Ga-Labeled Peptide-Based Heterodimers for Dual Targeting of NTS1 and GRPR.

Journal: ChemMedChem

Published: October 28, 2024

Gastrin-Releasing Peptide Receptor Imaging and Therapy in the Era of Personalized Medicine.

Gastrin-Releasing Peptide Receptor Imaging and Therapy in the Era of Personalized Medicine.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: October 22, 2024

Showing 1-12 of 46

Last Updated: 09/26/2026